陈士奇, 王春萌. 透明细胞肉瘤的治疗现状和进展[J]. 中国肿瘤临床, 2018, 45(22): 1169-1172. DOI: 10.3969/j.issn.1000-8179.2018.22.874
引用本文: 陈士奇, 王春萌. 透明细胞肉瘤的治疗现状和进展[J]. 中国肿瘤临床, 2018, 45(22): 1169-1172. DOI: 10.3969/j.issn.1000-8179.2018.22.874
Shiqi Chen, Chunmeng Wang. Current status and progress of treatment for clear cell sarcoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 45(22): 1169-1172. DOI: 10.3969/j.issn.1000-8179.2018.22.874
Citation: Shiqi Chen, Chunmeng Wang. Current status and progress of treatment for clear cell sarcoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 45(22): 1169-1172. DOI: 10.3969/j.issn.1000-8179.2018.22.874

透明细胞肉瘤的治疗现状和进展

Current status and progress of treatment for clear cell sarcoma

  • 摘要: 透明细胞肉瘤(clear cell sarcoma, CCS)是一种罕见但高度恶性的软组织肿瘤, 多发于青少年和中年人群中肢体的肌腱和腱膜组织。目前CCS治疗多采取手术为主的综合治疗。由于CCS对传统化疗和放疗具有高度抵抗性, 因此化疗和放疗疗效较为有限。随着近年在CCS发病机制等方面的研究, 靶向治疗在CCS的治疗中发挥着重要作用, 免疫治疗作为一种新的治疗方法也有个案报道。基于其放化疗不敏感和易复发转移的特性, 对于特定患者选择合适的治疗方案具有重要意义。由于CCS发病率低, 尚未有大样本量的临床研究, 本文就CCS的临床治疗现状和进展进行综述, 旨在为CCS的研究和治疗提供参考。

     

    Abstract: Clear cell sarcoma (CCS) is a rare, aggressive soft tissue sarcoma that primarily affects adolescents and young adults and typically involves tendons and aponeuroses.Currently, systematic treatment based on surgery is mainly adopted for CCS; the outcomes of chemotherapy and radiotherapy are poor due to the high resistance.With the progression in research regarding CCS pathogenesis, targeted therapy and immunotherapy are becoming increasingly important in the treatment of CCS.However, CCS has a high rate of local recurrence and distant metastasis, so it is urgent to identify comprehensive treatment regimens.This article reviews the current status and progress of treatment for CCS to provide information for clinical practice.

     

/

返回文章
返回